Skip to main content
PMC home page
Journal of the Royal Society of Medicine logoLink to Journal of the Royal Society of Medicine
. 1980 Aug;73(8):561–566. doi: 10.1177/014107688007300805

Preoperative assessment and staging of breast cancer: preliminary communication1

A P M Forrest, R B Black, V Humeniuk
PMCID: PMC1437852  PMID: 7230232

Abstract

A prospective study has been carried out in 172 women to determine the sensitivity of methods to detect occult metastatic disease in the skeleton and liver. With the exception of bone scintiscans, the results of these tests bore little relationship to recurrence rates. On the other hand, knowledge of the histopathology of the lower axillary (pectoral) lymph nodes is of value in this respect.

A follow-up study is also reported which confirms the importance of accurate measurements of the primary tumour clinical node status and oestrogen receptor contact of the tumour in defining prognostic groups. Elastosis (estimated in 165 tumours) did not prove to be a useful prognostic index.

Full text

PDF
561

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bishop H. M., Blamey R. W., Morris A. H., Rose D. H., Preston B., Lane J., Doyle P. J. Bone scanning: its lack of value in the follow-up of patients with breast cancer. Br J Surg. 1979 Oct;66(10):752–754. doi: 10.1002/bjs.1800661020. [DOI] [PubMed] [Google Scholar]
  2. Burkett F. E., Scanlon E. F., Garces R. M., Khandekar J. D. The value of bone scans in the management of patients with carcinoma of the breast. Surg Gynecol Obstet. 1979 Oct;149(4):523–525. [PubMed] [Google Scholar]
  3. Cant E. L., Smith A. F., Sumerling M. D., Forrest A. P. "Superstaging" in breast cancer--a correlation of lymph node histology and investigations designed to detect occult metastatic disease. World J Surg. 1977 May;1(3):303–305. doi: 10.1007/BF01556843. [DOI] [PubMed] [Google Scholar]
  4. Cooke T., George D., Shields R., Maynard P., Griffiths K. Oestrogen receptors and prognosis in early breast cancer. Lancet. 1979 May 12;1(8124):995–997. doi: 10.1016/s0140-6736(79)92752-1. [DOI] [PubMed] [Google Scholar]
  5. Coombes R. C., Powles T. J., Gazet J. C., Nash A. G., Ford H. T., McKinna A., Neville A. M. Assessment of biochemical tests to screen for metastases in patients with breast cancer. Lancet. 1980 Feb 9;1(8163):296–297. doi: 10.1016/s0140-6736(80)90790-4. [DOI] [PubMed] [Google Scholar]
  6. Forrest A. P., Cant E. L., Roberts M. M., Stewart H. J., Sumerling M. D., Donaldson A. A., Smith A. F., Shivas A. A. Is the investigation of patients with breast cancer for occult metastatic disease worth while? Br J Surg. 1979 Oct;66(10):749–751. doi: 10.1002/bjs.1800661019. [DOI] [PubMed] [Google Scholar]
  7. Hawkins R. A., Hill A., Freedman B. A simple method for the determination of oestrogen receptor concentrations in breast tumours and other tissues. Clin Chim Acta. 1975 Oct 15;64(2):203–210. doi: 10.1016/0009-8981(75)90202-8. [DOI] [PubMed] [Google Scholar]
  8. Kiang D. T., Frenning D. H., Goldman A. I., Ascensao V. F., Kennedy B. J. Estrogen receptors and responses to chemotherapy and hormonal therapy in advanced breast cancer. N Engl J Med. 1978 Dec 14;299(24):1330–1334. doi: 10.1056/NEJM197812142992403. [DOI] [PubMed] [Google Scholar]
  9. Knight W. A., Livingston R. B., Gregory E. J., McGuire W. L. Estrogen receptor as an independent prognostic factor for early recurrence in breast cancer. Cancer Res. 1977 Dec;37(12):4669–4671. [PubMed] [Google Scholar]
  10. Masters J. R., Hawkins R. A., Sangster K., Hawkins W., Smith I. I., Shivas A. A., Roberts M. M., Forrest A. P. Oestrogen receptors, cellularity, elastosis and menstrual status in human breast cancer. Eur J Cancer. 1978 Mar;14(3):303–307. doi: 10.1016/0014-2964(78)90194-9. [DOI] [PubMed] [Google Scholar]
  11. Maynard P. V., Blamey R. W., Elston C. W., Haybittle J. L., Griffiths K. Estrogen receptor assay in primary breast cancer and early recurrence of the disease. Cancer Res. 1978 Nov;38(11 Pt 2):4292–4295. [PubMed] [Google Scholar]
  12. Wallace I. W., Champton H. R. Axillary nodes in breast cancer. Lancet. 1972 Jan 29;1(7744):217–218. doi: 10.1016/s0140-6736(72)90619-8. [DOI] [PubMed] [Google Scholar]
  13. Walt A. J., Singhakowinta A., Brooks S. C., Cortez A. The surgical implications of estrophile protein estimations in carcinoma of the breast. Surgery. 1976 Oct;80(4):506–512. [PubMed] [Google Scholar]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press

RESOURCES